EPC director granted 7,817 restricted stock equivalents

Edgewell Personal Care Company director receives equity grant.

Rhea-AI Filing Summary

Edgewell Personal Care Company director receives equity grant. Director John C. Hunter III was granted 7,817 restricted stock equivalents of Edgewell common stock at a price of $0 on 02/05/2026. These restricted stock equivalents convert into common shares on the day before the next annual shareholder meeting, unless he elects to defer conversion until his service on the Board ends.

Insider Trade Summary

Grant/Award: 7,817 shares

Grant/Award 1 txn

Insider HUNTER JOHN C III

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Equivalents 2-5-2026	7,817	$0.00	$0.00

Holdings After Transaction: Restricted Stock Equivalents 2-5-2026 — 7,817 contracts (Direct)

Footnotes (1)

1. F1. Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did EPC director John C. Hunter III report?

Director John C. Hunter III reported an award of 7,817 restricted stock equivalents. These derivative securities were granted at a price of $0 and will convert into Edgewell common stock according to the company’s director compensation terms tied to the next annual shareholder meeting.

How many restricted stock equivalents did the EPC director receive on February 5, 2026?

On February 5, 2026, the director received 7,817 restricted stock equivalents. This entire amount remains beneficially owned following the transaction and represents equity-based compensation rather than an open-market purchase or sale of Edgewell Personal Care common stock.

At what price were the EPC restricted stock equivalents granted to the director?

The restricted stock equivalents were granted at a price of $0 per unit. This reflects a compensatory equity award for board service, rather than a cash purchase, and will convert into shares of Edgewell common stock based on the plan’s stated conditions.

When do the EPC restricted stock equivalents convert into common stock?

The restricted stock equivalents convert into Edgewell common stock on the day preceding the next annual meeting of shareholders. The reporting director may instead elect to defer this conversion until his termination of service on Edgewell’s Board of Directors, according to the filing footnote.

Is the EPC director’s restricted stock equivalent holding direct or indirect?

The filing shows the 7,817 restricted stock equivalents as directly owned. The ownership form is marked as “D” for direct, and no footnote indicates that the securities are held through a trust, partnership, or other indirect entity on behalf of the reporting person.

Does the EPC Form 4 reflect any sale of common stock by the director?

The Form 4 does not report any sale of common stock by the director. It reports an acquisition coded “A” of 7,817 restricted stock equivalents, which are derivative securities that will later convert into Edgewell Personal Care common stock under the plan’s terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 10:47 AM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HUNTER JOHN C III

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Equivalents 2-5-2026	$0	02/05/2026		A		7,817		(1)	(1)	Common Stock	7,817	$0	7,817	D

Explanation of Responses:

1. Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

	/s/ LaTanya Langley	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.